ONTTF News and Press, Oxford Nanopore

2026-03-11 17:42:17 ET Oxford Nanopore Technologies plc (ONTTF) Barclays 28th Annual Global Healthcare Conference March 11, 2026 3:30 PM EDT... Read the full article on Seeking Alpha For further details see: Oxford Nanopore Technologies plc (ONTTF) Presents at Barclays 28th ...

2026-03-02 17:37:49 ET Oxford Nanopore Technologies plc (ONTTF) Q4 2025 Earnings Call March 2, 2026 5:45 AM EST... Read the full article on Seeking Alpha For further details see: Oxford Nanopore Technologies plc (ONTTF) Q4 2025 Earnings Call Transcript

2026-03-02 15:58:46 ET More on Oxford Nanopore Technologies plc Financial information for Oxford Nanopore Technologies plc Read the full article on Seeking Alpha For further details see: Oxford Nanopore reports FY results

2026-01-12 19:55:57 ET Oxford Nanopore Technologies plc (ONTTF) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 5:15 PM EST... Read the full article on Seeking Alpha For further details see: Oxford Nanopore Technologies plc (ONTTF) Presents at 44th Annual J.P....

2026-01-06 07:16:59 ET More on Thermo Fisher Scientific, Danaher, etc. Thermo Fisher: Refinding Some Momentum Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference...

2025-12-18 11:20:17 ET Although the shares of long-read sequencing specialist Pacific Biosciences of California, Inc. ( PACB ) (“PacBio”) have done better of late, rising more than 25% since my last "Buy" update in February and outperforming both Illumina ( ILMN ) ...

2025-12-02 12:53:28 ET Oxford Nanopore Technologies plc (ONTTF) Citi Annual Global Healthcare Conference 2025 December 2, 2025 9:45 AM EST... Read the full article on Seeking Alpha For further details see: Oxford Nanopore Technologies plc (ONTTF) Presents at Citi Annual Glob...

2025-09-02 07:45:40 ET Oxford Nanopore Technologies plc (ONTTF) Q2 2025 Earnings Call September 2, 2025 3:30 AM EDT... Read the full article on Seeking Alpha For further details see: Oxford Nanopore Technologies plc (ONTTF) Q2 2025 Earnings Call Transcript

2025-03-05 08:30:00 ET Summary Illumina faces significant challenges from China's "unreliable entity list" and competition from Roche's new SBX technology, impacting its growth prospects. Despite a 37% stock decline since August, Illumina remains a leader in NGS with promising lon...

2025-03-04 15:42:05 ET Oxford Nanopore Technologies plc (ONTTF) Q4 2024 Results Conference Call March 04, 2025 04:30 AM ET Company Participants Gordon Sanghera - Chief Executive Officer Nick Keher - Chief Financial Officer Conference Call Participants Cha...